TRICARE Pharmacy Program RFI
Closed Special Notice Posted
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 524114 Direct Health and Medical Insurance Carriers
- PSC
- Q201 Medical- Managed Healthcare
- Place of performance
- Aurora, Colorado, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency (DHA) has issued a Request for Information (RFI) for the next generation TRICARE Pharmacy Program (TPharm) contract. This Special Notice, posted on December 16, 2025, represents the initial phase of market research and acquisition planning for a significant healthcare services contract. The RFI is not a formal solicitation and does not constitute a commitment by the Government to issue a contract or accept any proposals. Responses will be used exclusively for market research purposes to inform the development of requirements and program design. The DHA emphasizes that no costs associated with responding will be reimbursed and that responses may be subject to release under the Freedom of Information Act unless appropriately marked as confidential.
The primary objective of this RFI is to gather industry feedback on the design and implementation of pharmacy benefit administration services for approximately 9.6 million beneficiaries, including active-duty personnel, retirees, and their dependents. Interested vendors must submit responses by January 30, 2026, and are required to complete an online capability survey along with a 10-page written response addressing six key areas: pharmacy benefit administration services, mail order pharmacy fulfillment, specialty pharmacy programs, management controls, preferred procurement methods, and operational barriers. While no specific eligibility restrictions are stated in the notice, participation is open to qualified pharmacy benefit administrators and related service providers. The program encompasses multiple service delivery channels including military treatment facilities, retail network pharmacies, and the TRICARE Mail Order Pharmacy, and operates under a replenishment model where the contractor maintains base inventory with replacements supplied by the DLA's National Prime Vendor. The Government is exploring potential multi-award contract structures based on regions or task areas, and further clarification opportunities will be available during the formal RFP stage.
Notice text
The Defense Health Agency (DHA) is in the acquisition planning phase for the next generation TRICARE Pharmacy Program (TPharm) contract. This Request For Information (RFI) is the method for initiating market research efforts as the Government begins to build requirements and documentation related to this program.
Disclaimer:
This announcement does not constitute a commitment, implied or otherwise that a solicitation or contract will be issued. Issuance of the RFI is for planning purposes only and does not commit the Government to any contractual agreements or arrangements. The Government is not soliciting proposals with this request.
Please note that the collection of the requested information does not obligate the Government to incorporate solicited comments or procure any services. Responses to this announcement will not be returned. The Government is not liable to pay any costs associated with companies responding to this announcement.
Issuance of the RFI is intended to provide interested parties with information on the anticipated procurement and provide an opportunity for industry feedback into the preliminary programmatic design. All information received resulting from this RFI will be used by the DHA as market research. However, responses may be releasable to the public under the Freedom of Information Act (FOIA) unless appropriately marked.
The DHA, at its discretion, may request respondents to elaborate on information in their written response in writing or through other means. Respondents will not be notified of any results derived from a review of the information provided.
Any responses from the Government are subject to change, as the requirements themselves remain in draft form. Interested parties will have opportunity to seek clarification from the Government for any remaining questions, particularly those pertaining to evaluation criteria, incentives, or contract requirements, at the final RFP stage.
All responses must be provided via email to dha.buckley.ad-spt-cae.mbx.tpharm6@health.mil by January 30, 2026 12:00 pm MST.
Files
| File | Type | Posted |
|---|---|---|
| TPharm6 RFI.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| TRICARE Medicare Eligible Program Second Generation (TMEP2) | Defense Health Agency | No set-aside | |
| DHA - Offsite Sterile Processing Support Services | Defense Health Agency | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity